Enduring CME will expire on 5/11/2024

Learning Objectives:

• Improve their knowledge base in substance use disorder in adult patients

• Recognize appropriateness of in office treatment versus referral to specialized treatment programs

• Improve their knowledge base about medication for opioid use disorder (MOUD) and alcohol use disorder (AUD)

Accreditation and Designation:

The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.

The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Enduring CME will expire on 5/10/2024

Objectives:

Familiarize the audience with the latest robotic mitral valve technology

Detail methods of repair including a live case

Education audience on the overlap between transcatheter structural heart technology and robotic cardiac surgery.

Disclosures:

- There is no commercial support for this activity

- The speaker has disclosed the following financial relationships:

- Advisory Board – Regeneron

- Speaker Bureau – Boehringer Ingelheim, Amgen, and Esperion

Accreditation and Designation:

The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.

The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Objectives:

Recognize the association between post-COVID syndrome (or long COVID syndrome) and post-COVID tachycardia.

Identify the difference between post-COVID tachycardia and inappropriate sinus tachycardia and postural orthostatic tachycardia syndrome.

Discuss the demographics, comorbidities and severity of COVID-19 infection associated with post-COVID tachycardia.

Objectives:

Understand the pathophysiology of chronic subdural hematomas

Know the techniques for neurointervention in subdural hematoma

Review the recent research outcomes on endovascular techniques in chronic subdural hematomas

Objectives:

•Understand Heart Failure with Preserved Ejection Fraction (HFpEF), including definitions, signs, symptoms, and risk factors.

•Discuss the proposed pathophysiology of heart failure with both preserved and reduced ejection fractions.

•Review the new trial called “MyPACE” to discuss effects of personalized accelerated pacing in patients with HFpEF.

Objectives:

• Examine what is POLST and its use in Northeast Georgia Health System.

• Review patient criteria for POLST qualification.

• Understand POLST’s role in assisting patients with expressing their medical wishes.

• Recognize when POLST is appropriate for patient completion.

Today's Speaker: ZAHI A. FAYAD, PHD, FAHA, FACC, FISMRM

Director, BioMedical Engineering and Imaging Institute

Professor of Medicine, Division of Cardiology

Icahn School of Medicine, Mount Sinai School, NY

Disclosures: Grant/research support from NIH. Consultant for Trained Therapeutix Discovery and Co-founder/Board of directors for Trained Therapeutix Discover.

Objectives:

•Understand personalized patient care.

How to implement personalized care.

Understand the expected outcomes from personalized care.

Today's Speaker: Rosemary Chofor, MD

IM Resident, PGY-3

Objectives:

• Define polypharmacy and deprescribing.

• Recognize patients at risk for deleterious effects of polypharmacy.

• Integrate screening tools when completing medication reconciliation.

• List the strategies that can help minimize polypharmacy.

Today's Speaker: Speaker: Oluseyi Abidoye, MD

Objectives:

- Review and understand the pathophysiology of VTEs in patients with traumatic fractures

- Understand role of Antithrombotic agents in preventing VTEs in post-surgical patients

- Review current guidelines of VTE prevention in patients with fractures

- Understand the Role of Aspirin as a single agent for venous thrombophylaxis in patients after extremity fracture

Today's Speaker: Sahil Parag, DO

IM Resident, PGY-3

Objectives:

1. Understand the mechanism of action of Finerenone, and how it differs from currently used mineralocorticoid receptor antagonists

2. Identify patients that may benefit from addition of this medication

3. Understand adverse effects and monitoring for these patients

4. Identify the recommendations for specific population that may benefit from use of this medication along with current guidelines

5. Understand patients who this medication would be contraindicated despite have ckd and diabetes